EcoDrugPlus

Alk Receptor Tyrosine Kinase

Ensembl ID : ENSVPAG00000004035
Gene Symbol: ALK
1 Cross references
194 Possible Orthologues:

Atp Binding Cassette Subfamily B Member 1

Ensembl ID : ENSVPAG00000009894
Gene Symbol: ABCB1
1 Cross references
161 Possible Orthologues:

Atp Binding Cassette Subfamily C Member 8

Ensembl ID : ENSVPAG00000005360
Gene Symbol: ABCC8
1 Cross references
237 Possible Orthologues:

Atp Binding Cassette Subfamily C Member 9

Ensembl ID : ENSVPAG00000007552
Gene Symbol: ABCC9
1 Cross references
232 Possible Orthologues:

Atpase Na+/k+ Transporting Subunit Beta 3

Ensembl ID : ENSVPAG00000004686
Gene Symbol: ATP1B3
1 Cross references
299 Possible Orthologues:

Atr Serine/threonine Kinase

Ensembl ID : ENSVPAG00000004691
Gene Symbol: ATR
1 Cross references
206 Possible Orthologues:

B-Raf Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSVPAG00000001660
Gene Symbol: BRAF
3 Cross references
220 Possible Orthologues:

Bcl2 Related Protein A1

Ensembl ID : ENSVPAG00000004433
Gene Symbol: BCL2A1
1 Cross references
114 Possible Orthologues:

Bruton Tyrosine Kinase

Ensembl ID : ENSVPAG00000006483
Gene Symbol: BTK
1 Cross references
207 Possible Orthologues:

C-C Motif Chemokine Receptor 1

Ensembl ID : ENSVPAG00000006553
Gene Symbol: CCR1
1 Cross references
299 Possible Orthologues:

C-C Motif Chemokine Receptor 2

Ensembl ID : ENSVPAG00000000516
Gene Symbol: CCR2
1 Cross references
286 Possible Orthologues:

C-C Motif Chemokine Receptor 9

Ensembl ID : ENSVPAG00000009770
Gene Symbol: CCR9
1 Cross references
262 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).